Chewing gum: alternative therapy to oxygen intolerance.

Area of Science:

• Pediatric Pulmonology
• Neurology
• Sleep Medicine

Background:

• Rapid-onset obesity with hypothalamic dysregulation, hypoventilation, and autonomic dysregulation (ROHHAD) syndrome is a rare disorder affecting multiple systems.
• Patients with ROHHAD syndrome often exhibit sleep-disordered breathing, which can lead to life-threatening cardiorespiratory events if untreated.
• Recent observations suggest central breathing pauses during wakefulness in ROHHAD syndrome patients, causing intermittent oxygen desaturations.

Observation:

• A case of ROHHAD syndrome presented with irregular breathing and significant central pauses during wakefulness, leading to oxygen desaturations.
• The patient's respiratory status, including oxygen saturation, improved notably while actively chewing gum.

Findings:

• Chewing gum demonstrated a positive effect on respiratory irregularities and oxygen desaturation in a child with ROHHAD syndrome during wakefulness.
• This intervention served as a potential alternative to conventional supplemental oxygen therapy.

Implications:

• Chewing gum may represent a novel, non-invasive therapeutic approach for managing respiratory disturbances in ROHHAD syndrome.
• Further research is warranted to explore the mechanism and efficacy of chewing gum as an alternative therapy for oxygen intolerance in pediatric patients.
• This finding highlights the importance of exploring alternative interventions for managing complex respiratory conditions in rare diseases.